15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 1 firms covering TrueBlue Inc, 1 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $6.00 to $6.00, so the covering firms are broadly aligned. The average target of $6.00 sits 23% below the current $7.80. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.17 next quarter toward $0.62 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS1 ratings
Moderate Buy
Strong Buy00%
Buy1100%
Hold00%
Sell00%
Strong Sell00%
Based on 1 analysts giving stock ratings to TrueBlue Inc.
As of Jul, 1 of 1 firms rate TBI a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
TBI EPS & revenue forecast
EPS · NEXT QUARTER
$0.17
Range $0.15 – $0.21 · 3 analysts · +478% YoY
Next period, 3 analysts expect TrueBlue Inc to earn $0.17 a share (range $0.15 – $0.21), versus $0.03 a year earlier. Full-year consensus is $-0.24, growing to $0.62 the year after.
REVENUE · NEXT QUARTER
$452.9M
Range $452.9M – $452.9M · 3 analysts · +5% YoY
Revenue is expected to reach $452.9M (range $452.9M – $452.9M), +5.0% year-over-year. Full-year consensus is $1.7B, rising to $1.7B next year.
Top analysts covering TrueBlue Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on TBI.
#1
Jeffrey Silber
BMO Capital · Rank #269
Buy
$6.00-23.1% to target
Overall win rate
31%
+ Follow
#2
MM
Mark Marcon
Baird
Buy
$5.50-29.5% to target
Coverage
—
+ Follow
TBI stock forecast FAQ
What is TBI's average 12-month price target?+
The 1 analysts with a live target average $6.00 for TrueBlue Inc over the next 12 months, ranging from a $6.00 high to a $6.00 low.
Is TBI stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 1 analyst ratings, 1 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
How many Wall Street analysts cover TBI?+
1 analysts have an active rating on TrueBlue Inc, and 1 firms carry a live 12-month price target.
Who is the most accurate analyst covering TBI?+
Among analysts who currently cover TBI, Jeffrey Silber of BMO Capital has the strongest overall Quantellect track record (Rank #269). Their current call is Buy with a $6.00 target.
What is TrueBlue Inc's projected EPS for next quarter?+
The consensus estimate is $0.17 per share (range $0.15 – $0.21) across 3 analysts. Full-year EPS is projected at $-0.24, rising to $0.62 the following year.
How much revenue is TrueBlue Inc expected to report next quarter?+
Consensus revenue is $452.9M (range $452.9M – $452.9M). Full-year revenue is projected at $1.7B, growing to $1.7B next year.
Have analysts been upgrading or downgrading TBI lately?+
As of Jul, 1 of 1 firms rate TBI a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their TBI calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
